Literature DB >> 34247746

Uremic Toxins and Cardiovascular System.

Sophie Valkenburg1, Griet Glorieux1, Raymond Vanholder2.   

Abstract

When chronic kidney disease develops, the capacity of the kidneys to clear metabolic waste products from the body is gradually lost. This process results in the retention of a large array of compounds affecting biochemical and biological functions (uremic toxins), of which several can cause cardiovascular damage. This article reviews the main cardiotoxic mechanisms related to uremic toxin retention (endothelial dysfunction, vascular smooth muscle cell alterations, inflammation, mineral bone disorder, insulin resistance, and thrombogenicity) and the main responsible retention compounds. Therapeutic options are reviewed, such as influencing solute generation by intestinal microbiota.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiorenal syndrome; Cardiovascular damage; Kidney damage; Pathophysiology; Uremic toxins

Year:  2021        PMID: 34247746     DOI: 10.1016/j.ccl.2021.04.002

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

Review 1.  Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Angela Yee-Moon Wang; Robert Kalyesubula; Elke Schaeffner; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2022-09-14       Impact factor: 42.439

Review 2.  [Long-term physical and psychological consequences of chronic kidney disease].

Authors:  Friedrich Thaiss
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-03-21       Impact factor: 1.513

3.  New Strategies for the Reduction of Uremic Toxins: How Much More We Know.

Authors:  Maria Teresa Rocchetti
Journal:  Toxins (Basel)       Date:  2021-11-24       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.